Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease; Focus on the Patient's Preferences and Life Situation
试验速览
- 阶段
- 不适用
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Health-Related Quality of Life (HRQoL) - General
研究概览
简要总结
The aim of this study is to adjust and test an existing internet-based tool for collecting patient-reported outcome measures and to use the internet-based tool in an multidisciplinary follow-up of patients treated for malignant hematological diseases. The patient-reported outcome measurements will be used in describing the patients' health-related quality of life (HRQoL) and to investigate whether the HRQol will increase due to participation in multidisciplinary follow-up.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients diagnosed with malignant hematological disease; Morbus Hodgkin and B- and T-cell disease
- •patients followed before or after
- •line treatment
- •patients in stable phase > 6 months after
- •line treatment
- •the patients participation in the study must be assessed and decided by the doctor responsible for the patient's course of treatment
排除标准
- •Health conditions which demands close medical monitoring
- •conditions which compromise the ability to understand the study and submit informed consent (ex.: dementia and severe mental illness / disability)
- •lack of capability to fill out electronic questionnaires
- •poor self-care and/or compliance
结局指标
主要结局
Health-Related Quality of Life (HRQoL) - General
时间窗: HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is SF-36. SF-36 is a generic questionnaire which can be used to assess HRQoL in the general public.
Health-Related Quality of Life (HRQoL) - Disease specific
时间窗: HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is EORTC C30 QLQ. EORTC C30 QLQ is a disease specific questionnaire which can be used to assess HRQoL in patients diagnosed with cancer
次要结局
- Symptoms of hematological disease(Symptoms of disease will be assessed every 2, 3, 4 or 6 month, up to 18 months)
- Symptoms of depression and anxiety(Symptoms of depression and anxiety will be assessed every 2, 3, 4 or 6 month, up to 18 months)
研究者
Mia Sommer
Clinical Research Nurse, ph.d. student
Aalborg University Hospital